This study was presented by Dr Johann Christian Virchow (Germany) et al., at the European Respiratory Society Congress (ERS) Congress 2024 held in Vienna, Austria.

This Cohort study results was presented by Mr. Michael Pollack et al from the BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA at the ERS Congress 2024

This study was presented by Dr Priti Meshram (Mumbai, India) et al., at the European Respiratory Society Congress (ERS) Congress 2024 held in Vienna, Austria.

This study was presented by Dr Mohamed Hamouda (United Arab Emirates) et al., at the European Respiratory Society Congress (ERS) Congress 2024 held in Vienna,

This retrospective analysis was presented by Prof. Nikita Ermolaev et al. from Medical University of Vienna, Vienna, Austria at the ERS Congress 2024 in Vienna,

This study was presented by Prof Pernilla Sönnerfors et al. from Respiratory Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden at the ERS

This session was presented by Adzoa Ekue et al. from Mereo BioPharma Group plc, London, United Kingdom. at the ERS Congress 2024 in Vienna, Austria.

These phase 2 trial results was presented by Dr Professor Frits Franssen et al. from Maastricht University Medical Centre Netherlands at the ERS Congress 2024

This study was presented by Dr Luis Javier Nannini et al. from Pulmonary Section, Hospital E Perón, Universidad Nacional Rosario, Granadero Baigorria, Argentina at the

This case report was presented by Prof. Antonio Maiorano et al from Department of Health Sciences, University “Magna Graecia” of Catanzaro, Catanzaro, Italy at the